PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Total saponin fraction (TSDN) improved symptoms in rats by modulating M1/M2 macrophage polarization and suppressing NET formation [PMID:36607587, PMID:37614416]
Dioscin (DDN) ameliorated bone destruction, synovial inflammation, and cartilage tissue destruction in collagen-induced arthritis mouse models [PMID:39798473]
Inhibited DNA synthesis and cell cycle re-entry in vitro and decreased tumor volume and weight (26-50%) in xenograft mouse models [PMID:40391177]
Extract inhibited migration and invasion of Huh7 cell lines by inhibiting u-PA and MMP-9 [PMID:26916922]
Diosgenin demonstrated ameliorated effects via phosphorylation deactivation [PMID:35140607]
Evidence summary
PubMed sources
- 1.PMID: 38897248 (2024) — Diarylheptanoid glycosides from Dioscorea nipponica rhizomes. · Fitoterapia
- 2.PMID: 40633860 (2025) — Dioscorea nipponica Makino: Unraveling multi-target mechanisms and clinical potential in autoimmune disease therapy. · Journal of ethnopharmacology
- 3.PMID: 29748731 (2018) — Dioscorea nipponica Makino: a systematic review on its ethnobotany, phytochemical and pharmacological profiles. · Chemistry Central journal
- 4.PMID: 37716118 (2023) — Dioscorea nipponica Makino: A comprehensive review of its chemical composition and pharmacology on chronic kidney disease. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 5.PMID: 40391177 (2025)